PRPH - ProPhase Labs Inc logo

PRPH

ProPhase Labs Inc

ProPhase Labs develops and commercializes drugs, dietary supplements, and diagnostics. It offers products for male enhancement and energy, cancer diagnostic tests, genome sequencing services, and COVID-19 testing, catering to both consumers and healthcare providers.

โš•๏ธ Healthcare NASDAQ Listed 1997 $ USD
$1,000 invested 30 years ago โ†’$7today

Score Overview

1 Year
Score
Net Growth-63.22%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-21.93%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.2
Net Growth-483.60%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-95.71%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-6x
Net Trend50%
Net Income Consistency
Rev Growth-83.86%
Rev Trend40%
Revenue Consistency
20 Years
Score2.3
Net Growth-11x
Net Trend60%
Net Income Consistency
Rev Growth-91.95%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-214.59%
Net Trend52%
Net Income Consistency
Rev Growth-95.17%
Rev Trend45%
Revenue Consistency

See the full market ranking โ†’

ProPhase Labs Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 14M to $ 4M and net income went from -$ 2M to -$ 14M. Revenue increased in 1 of those 5 years; net income in 2.

Across ProPhase Labs Inc's full reported history, from 1997 to 2025, revenue declined from $ 70M to $ 4M and net income went from $ 21M to -$ 14M. Revenue increased in 45% of the years measured; net income in 52%.

ProPhase Labs Inc currently holds a 20-year HDB Score of 2.3 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-11
$ 0.05โ€”
1 Year2025-08-12
$ 3.54-98.60%
5 Years2021-08-12
$ 59.76-99.92%
10 Years2016-08-12
$ 7.79-99.36%
20 Years2006-08-11
$ 34.92-99.86%
30 Years1996-08-12
$ 7.28-99.32%
All Time1997-01-16
$ 51.06-99.90%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 3M-$ 24M$ 31K
2025$ 4M-$ 14M$ 90K
2024$ 6M-$ 53M$ 678K
2023$ 44M-$ 16M$ 4M
2022$ 122M$ 18M$ 17M
2021$ 79M$ 6M$ 17M
2020$ 14M-$ 2M$ 8M
2019$ 9M-$ 3M$ 1M
2018$ 13M-$ 1M$ 8M
2017$ 9M$ 41M$ 21M
2016$ 21M-$ 2M$ 441K
2015$ 20M-$ 3M$ 1M
2014$ 22M-$ 7M$ 2M
2013$ 25M$ 405K$ 1M
2012$ 22M-$ 1M$ 572K
2011$ 17M-$ 2M$ 5M
2010$ 14M-$ 3M$ 8M
2009$ 19M-$ 3M$ 12M
2008$ 20M-$ 5M$ 11M
2007$ 39M-$ 2M$ 16M
2006$ 42M-$ 1M$ 17M
2005$ 53M$ 3M$ 16M
2004$ 43M$ 452.86K$ 14M
2003$ 41M$ 674.57K$ 11M
2002$ 29M-$ 6M$ 12M
2001$ 24M$ 215.96K$ 9M
2000$ 19M-$ 5M$ 11M
1999$ 24M-$ 4M$ 14M
1998$ 36M$ 6M$ 28M
IPO1997$ 70M$ 21M$ 25M

Explore beyond PRPH

You're looking at ProPhase Labs Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies